1. Home
  2. SNGX vs ICON Comparison

SNGX vs ICON Comparison

Compare SNGX & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • ICON
  • Stock Information
  • Founded
  • SNGX 1987
  • ICON 2023
  • Country
  • SNGX United States
  • ICON Greece
  • Employees
  • SNGX N/A
  • ICON N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • SNGX Health Care
  • ICON
  • Exchange
  • SNGX Nasdaq
  • ICON Nasdaq
  • Market Cap
  • SNGX 6.5M
  • ICON 5.2M
  • IPO Year
  • SNGX 1987
  • ICON 2024
  • Fundamental
  • Price
  • SNGX $1.28
  • ICON $2.89
  • Analyst Decision
  • SNGX
  • ICON Strong Buy
  • Analyst Count
  • SNGX 0
  • ICON 1
  • Target Price
  • SNGX N/A
  • ICON $4.50
  • AVG Volume (30 Days)
  • SNGX 2.7M
  • ICON 3.4M
  • Earning Date
  • SNGX 08-08-2025
  • ICON 09-09-2025
  • Dividend Yield
  • SNGX N/A
  • ICON 332.15%
  • EPS Growth
  • SNGX N/A
  • ICON N/A
  • EPS
  • SNGX N/A
  • ICON N/A
  • Revenue
  • SNGX $2,342.00
  • ICON $5,474,000.00
  • Revenue This Year
  • SNGX N/A
  • ICON $51.78
  • Revenue Next Year
  • SNGX N/A
  • ICON $51.90
  • P/E Ratio
  • SNGX N/A
  • ICON N/A
  • Revenue Growth
  • SNGX N/A
  • ICON 16.93
  • 52 Week Low
  • SNGX $1.09
  • ICON $1.60
  • 52 Week High
  • SNGX $8.55
  • ICON $154.00
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 34.55
  • ICON N/A
  • Support Level
  • SNGX $1.09
  • ICON N/A
  • Resistance Level
  • SNGX $1.88
  • ICON N/A
  • Average True Range (ATR)
  • SNGX 0.14
  • ICON 0.00
  • MACD
  • SNGX -0.01
  • ICON 0.00
  • Stochastic Oscillator
  • SNGX 22.78
  • ICON 0.00

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: